Brief: Ultimovacs Granted European Patent Approval For UV1
25/06/2019 14:53
June 25 (Reuters) - Ultimovacs ASA ULTIMO.OL :
* EUROPEAN PATENT APPROVAL FOR UV1
* PATENT COVERS PROTECTION FOR UV1 IN EUROPE UNTIL 2031
Source text for Eikon: ID:nObiPQ57Za
Further company coverage: ULTIMO.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant